[Federal Register Volume 63, Number 100 (Tuesday, May 26, 1998)]
[Notices]
[Pages 28512-28513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13847]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: Advisory Committee on Immunization Practices (ACIP).
Times and Dates: 8:15 a.m.-6:15 p.m., June 24, 1998; 8:00 a.m.-
4:00 p.m., June 25, 1998.
Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise a list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) Program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters to be Discussed: Agenda items include a summary of the
meeting on ``Evaluating the Role of Vaccines and Infectious Diseases
in Autoimmune Disease: Insulin Dependent (Type 1) Diabetes
Mellitus'; updates on the National Immunization Program; the Vaccine
Injury Compensation Program; the National Vaccine Program; and HIV
vaccine. Also on the agenda, a discussion of financial disclosure
and voting protocol for ACIP; rotavirus vaccine data on differences
in morbidity by socioeconomic group, update on cost benefit data,
use of vaccine in premature infants, and rotavirus disease in
immunocompromised persons; a review of changes in the draft rabies
vaccine recommendation; computer algorithms for ACIP
recommendations; hepatitis A vaccine; consolidate resolutions
currently included in the VFC Program; harmonizing recommendation on
combination vaccines with the American Academy of Pediatrics and the
American Academy of Family Physicians; use of lyme disease vaccine;
progress towards development of a revised influenza recommendation;
and intravenous immunoglobulin products. Other matters of relevance
among the Committee's objectives may be discussed.
[[Page 28513]]
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gloria A. Kovach, Committee
Management Specialist, CDC, 1600 Clifton Road, NE, M/S D50, Atlanta,
Georgia 30333, telephone 404/639-7250.
Dated: May 19, 1998.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention (CDC).
[FR Doc. 98-13847 Filed 5-22-98; 8:45 am]
BILLING CODE 4163-18-P
